» Articles » PMID: 19784719

Gastric Emptying, Small Intestinal Transit and Fecal Output in Dystrophic (mdx) Mice

Overview
Journal J Physiol Sci
Specialty Physiology
Date 2009 Sep 29
PMID 19784719
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Duchenne muscular dystrophy (DMD), which results from deficiency in dystrophin, a sarcolemma protein of skeletal, cardiac and smooth muscle, is characterized by progressive striated muscle degeneration, but various gastrointestinal clinical manifestations have been observed. The aim was to evaluate the possible impact of the dystrophin loss on the gastrointestinal propulsion in mdx mice (animal model for DMD). The gastric emptying of a carboxymethyl cellulose/phenol red dye non-nutrient meal was not significantly different at 20 min from gavaging between wild-type and mdx mice. The intestinal transit and the fecal output were significantly decreased in mdx versus normal animals, although the length of the intestine was similar in both animals. The present results provide evidence for motor intestinal alterations in mdx mice in in vivo conditions.

Citing Articles

Caveolin and NOS in the Development of Muscular Dystrophy.

Nakashima M, Suga N, Yoshikawa S, Matsuda S Int J Mol Sci. 2024; 25(16).

PMID: 39201459 PMC: 11354531. DOI: 10.3390/ijms25168771.


CFP/Yit: An Inbred Mouse Strain with Slow Gastrointestinal Transit.

Wagai G, Togao M, Kurakawa T, Nishizaki H, Otsuka J, Ohta-Takada Y Dig Dis Sci. 2024; 69(6):2026-2043.

PMID: 38622463 PMC: 11162387. DOI: 10.1007/s10620-024-08420-x.


Advancing Biomarker Discovery and Therapeutic Targets in Duchenne Muscular Dystrophy: A Comprehensive Review.

Molinaro M, Torrente Y, Villa C, Farini A Int J Mol Sci. 2024; 25(1).

PMID: 38203802 PMC: 10778889. DOI: 10.3390/ijms25010631.


Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy.

Kalkan H, Pagano E, Paris D, Panza E, Cuozzo M, Moriello C EMBO Mol Med. 2023; 15(3):e16225.

PMID: 36594243 PMC: 9994484. DOI: 10.15252/emmm.202216225.


Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin-deficient mice.

Farini A, Tripodi L, Villa C, Strati F, Facoetti A, Baselli G EMBO Mol Med. 2022; 15(3):e16244.

PMID: 36533294 PMC: 9994487. DOI: 10.15252/emmm.202216244.


References
1.
Mule F, Amato A, Vannucchi M, Faussone-Pellegrini M, Serio R . Altered tachykinergic influence on gastric mechanical activity in mdx mice. Neurogastroenterol Motil. 2006; 18(9):844-52. DOI: 10.1111/j.1365-2982.2006.00820.x. View

2.
Lefaucheur J, Pastoret C, Sebille A . Phenotype of dystrophinopathy in old mdx mice. Anat Rec. 1995; 242(1):70-6. DOI: 10.1002/ar.1092420109. View

3.
Sander M, Chavoshan B, Harris S, Iannaccone S, Stull J, Thomas G . Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc Natl Acad Sci U S A. 2000; 97(25):13818-23. PMC: 17659. DOI: 10.1073/pnas.250379497. View

4.
Chiba T, Bharucha A, Thomforde G, Kost L, Phillips S . Model of rapid gastrointestinal transit in dogs: effects of muscarinic antagonists and a nitric oxide synthase inhibitor. Neurogastroenterol Motil. 2002; 14(5):535-41. DOI: 10.1046/j.1365-2982.2002.00357.x. View

5.
Fraser R, Vozzo R, Di Matteo A, Boeckxstaens G, Adachi K, Dent J . Endogenous nitric oxide modulates small intestinal nutrient transit and activity in healthy adult humans. Scand J Gastroenterol. 2005; 40(11):1290-5. DOI: 10.1080/00365520510023710. View